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Research
AbstrACt
Objectives To assess the feasibility of delivering and 
evaluating a lifestyle programme for patients with 
colorectal cancer undergoing potentially curative 
treatments.
study design Non-randomised feasibility trial.
setting National Health Service (NHS) Tayside.
Participants Adults with stage I–III colorectal cancer.
Intervention The programme targeted smoking, alcohol, 
physical activity, diet and weight management. It was 
delivered in three face-to-face counselling sessions (plus 
nine phone calls) by lifestyle coaches over three phases 
(1: presurgery, 2: surgical recovery and 3: post-treatment 
recovery).
Primary outcome Feasibility measures (recruitment, 
retention, programme implementation, achieved measures, 
fidelity, factors affecting protocol adherence and 
acceptability).
secondary outcomes Measured changes in body weight, 
waist circumference, walking and self-reported physical 
activity, diet, smoking, alcohol intake, fatigue, bowel 
function and quality of life.
results Of 84 patients diagnosed, 22 (26%) were 
recruited and 15 (18%) completed the study. Median time 
for intervention delivery was 5.5 hours. Coaches reported 
covering most (>70%) of the intervention components 
but had difficulties during phase 2. Evaluation measures 
(except walk test) were achieved by all participants at 
baseline, and most (<90%) at end of phase 2 and phase 
3, but <20% at end of phase 1. Protocol challenges 
included limited time between diagnosis and surgery and 
the presence of comorbidities. The intervention was rated 
highly by participants but limited support from NHS staff 
was noted. The majority of participants (77%) had a body 
mass index>25 kg/m2 and none was underweight. Physical 
activity data showed a positive trend towards increased 
activity overall, but no other changes in secondary 
outcomes were detected.
Conclusions To make this intervention feasible for 
testing as a full trial, further research is required on (a) 
recruitment optimisation, (b) appropriate assessment 
tools, (c) protocols for phase 2 and 3, which can build 
in flexibility and (d) ways for NHS staff to facilitate the 
programme.
trial registration number ISRCTN52345929; Post-
results.
IntrOduCtIOn 
Colorectal cancer (CRC) survival has improved 
in the last decade due to earlier diagnosis and 
new treatments but, in Scotland, survivors still 
have notable excess mortality within the first 
year postdiagnosis compared with other Euro-
pean countries.1 Survivors also have a high 
rate of pre-existing comorbidities and treat-
ment-related symptoms. The latter are expe-
rienced by 15% undergoing colonic surgery, 
33% with rectal surgery, 50% of those with 
chemoradiation therapy and 66% of patients 
undergoing short course radiotherapy. These 
symptoms include fatigue, physical discom-
fort and bowel function problems.2
strengths and limitations of this study
 ► This feasibility study is the first to have offered a 
comprehensive lifestyle intervention programme 
at diagnosis with support before, during and after 
treatment in patients with colorectal cancer.
 ► The study highlights the wide range of variables 
that need to be considered in designing a future 
randomised controlled trial (including recruitment 
and support from National Health Service (NHS) 
staff, complexities of patient health status and 
time required for permissions, assessment and 
interventions).
 ► The lack of randomisation means it is not possible 
to estimate uptake to a randomised controlled trial.
 ► The work was undertaken in a single NHS health 
board and may not be representative of other treat-
ment centres.
 o
n
 15 June 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-021117 on 6 June 2018. Downloaded from 
2 Macleod M, et al. BMJ Open 2018;8:e021117. doi:10.1136/bmjopen-2017-021117
Open Access 
In people diagnosed with cancer, it is recognised that 
smoking cessation, improved physical activity and diet 
have the potential to impact on treatment outcomes and 
cancer recurrence. A number of studies have reported 
that higher levels of physical activity are associated 
with better physical functioning3 and reduced fatigue,4 
although further work is needed in this area.5 Follow-up 
studies report better disease-free, recurrence-free and 
overall survival in people who are more physically active.6 7 
Intervention trials have shown that higher levels of phys-
ical activity initiated at prehabilitation (presurgery), 
postsurgery, during and after adjuvant therapies (reha-
bilitation)8–10 are associated with improved cardiorespi-
ratory fitness, muscular strength, physical functioning, 
quality of life and reduced psychosocial distress.
There is growing evidence for the impact of diet on 
CRC cancer outcomes.11 A large observational study has 
reported that a higher level of a Western dietary intake 
(compared with a lower level of Westernisation) resulted 
in lower disease-free and overall survival rates.12 At inter-
vention level, a trial of dietary counselling delivered 
during treatment13 showed that nutrition improvements 
were associated with reduced treatment related comor-
bidity (radiotherapy toxicity) at 3 months and after a 
mean follow-up of 6 years. Three post-treatment explor-
atory trials14–16 of combined lifestyle interventions have 
reported improved dietary behaviour, reduced fatigue, 
improved exercise tolerance, functional capacity and 
quality of life.
There is some evidence to support lifestyle interventions 
in the presurgical and post-treatment periods, but no trial 
has yet evaluated an intervention covering the full patient 
journey. Patients report confusion about appropriate life-
style behaviours because they have received conflicting 
advice at different treatment stages and rarely receive 
personalised support in the period after treatments end 
and during return to normal health.17 It has been noted 
that relatively few patients with CRC stop smoking after 
diagnosis (13.7% prediagnosis to 9% 5 months later).18 
Current data suggest that, in patients with CRC, physical 
activity levels drop significantly by 6 months postdiag-
nosis.19 This may reflect lack of consistent guidance from 
clinicians, and patient confusion over the merits of rest 
versus activity.20 Similarly, for diet, misconceptions exist 
over body weight gain (or loss) and understanding of 
appropriate food selection.
There are a number of behavioural frameworks that 
could support lifestyle change from the start of care such 
as the concept of the ‘teachable moment’.21 Cancer care 
clinicians, starting at diagnosis and throughout the cancer 
pathway, can be powerful advocates to help patients 
understand the importance of a healthy lifestyle and they 
have expressed interest in providing guidance.22 Patients 
consider information obtained from cancer specialists to 
be of the best quality.20 Despite major concerns over their 
diagnosis, many patients request advice on what might 
be done to prepare for surgery and there is a need for 
clinicians to identify an effective programme with the 
potential to improve health in the first year after diagnosis. 
Increasingly, asymptomatic patients are diagnosed via 
the national bowel screening programme, which means 
that this patient group is less frail than those diagnosed 
late and have considerable potential to initiate lifestyle 
change. Opportunities in the ‘prehabilitation’ period 
have been highlighted in cancer strategy documents,23 
but little is known about likely uptake of interventions.
This study aimed to assess the practical aspects of deliv-
ering and evaluating a lifestyle intervention programme 
(TreatWELL) for patients with CRC undergoing poten-
tially curative treatments in order to inform the feasibility 
of undertaking a randomised controlled trial (RCT) to 
assess the clinical and cost-effectiveness of this interven-
tion at 1 year after diagnosis.
Specific objectives were to assess recruitment and reten-
tion to assist in the design of a future RCT, assess the feasi-
bility of data collection procedures, ease of programme 
implementation, patient acceptability, fidelity and factors 
influencing adherence to the intervention.
MethOds
study design and setting
This study was a single-arm, two-centre feasibility study of 
the TreatWELL intervention programme carried out in 
tertiary level teaching hospitals in Tayside, UK.
sample size
We aimed to recruit 34 participants in order to be able to 
assess feasibility objectives and to provide data to inform 
the sample size required to show significant differences 
in health outcome variables in a fully powered RCT. 
These numbers were based on a pragmatic assessment of 
patient numbers, eligibility and participation based on a 
previous study undertaken with the same patient group 
(at post-treatment stage) in the same geographic area.15
eligibility
Eligible patients were adults aged >18 years, capable of 
giving informed consent, considered to have stage I–III 
colorectal cancer, eligible for potentially curative treat-
ment (had to be fit for major surgery). It should be noted 
that participants were recruited before CT scans and 
eligibility was based on clinical examination. Patients who 
had severe cognitive impairment, emergency surgery or 
preoperative neoadjuvant therapy were excluded from 
the study.
recruitment
Eligible patients were introduced to the study by a clin-
ical nurse specialist (CNS) after discussing treatment and 
care plans following a cancer diagnosis. At this meeting, 
the CNS introduced the study and endorsed its impor-
tance for helping to achieve lifestyle change in the presur-
gical period. Interested patients were provided with a 
participant information sheet, an invitation and endorse-
ment letter from the lead CRC clinician for Tayside and a 
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prepaid opt-in reply slip, which they could return to the 
research team. A research nurse (RN) then contacted 
patients, who had either provided their contact details to 
the CNS or returned the prepaid reply slip, to discuss the 
study in detail and (if appropriate) make an appointment 
to obtain written informed consent and take baseline 
measurements. This appointment was held at the refer-
ring hospital or the participant’s home, if a hospital loca-
tion was reported as a barrier to participation.
Intervention
The TreatWELL intervention programme aimed to facil-
itate collaboratively agreed behaviour changes towards 
achieving and maintaining smoking cessation, increased 
physical activity (to at least 150 min moderate-intensity 
activity per week), caloric intake appropriate to weight 
status and a nutrient-dense diet. All goals were consis-
tent with the American Cancer Society and World Cancer 
Research Fund guidance for cancer survivors.24 25 The 
behavioural approaches were informed by two main 
theoretical frameworks: self-regulatory theory26 and the 
health action process approach.27
Following baseline measures, consented patients’ 
contact details were passed to a lifestyle coach (LC) who 
then commenced the TreatWELL personalised interven-
tion. The LCs had a nursing background, experience 
with cancer patient management and underwent a 3-day 
bespoke training programme covering smoking cessation, 
increasing moderate physical activity, brief interventions 
on alcohol and weight management (postsurgical and 
post-treatment). The intervention was delivered via three 
face-to-face contacts (one per intervention phase and a 
minimum of nine phone calls) supported by written liter-
ature and a range of behavioural techniques.
 ► Phase 1: prehabitation to start within 3–10 days of 
diagnosis to surgery.
 ► Phase 2: surgical recovery to start 1 day postoperative 
and aim to complete within 21 days.
 ► Phase 3: postsurgical/adjuvant therapy recovery to 
start 21 days postoperative for 25 weeks.
The total intervention period comprised 31 weeks, 
although duration was flexible as it was based on the indi-
vidual’s treatment regimen. The delivery mode, consulta-
tion focus, resources and behaviour change techniques 
used in each phase are presented in online supplemen-
tary appendix 1. Decisions about phase completion (eg, 
defining the end of postsurgical recovery) and progres-
sion was agreed in conjunction with the CNS. In summary, 
each phase of the programme comprised verbal educa-
tional approaches with written resources (eg, booklets, 
resistance bands) and the use of behavioural techniques. 
Importantly, personalised, specific action goals were iden-
tified with a focus on two health behaviours that were 
selected as a priority for that individual (eg, smoking, 
physical activity). All participants were invited to engage 
a support person (eg, spouse) to assist in their adherence 
with the programme. It should be noted that the protocol 
for phase 3 varied according to chemotherapy use. For 
patients with no adjuvant therapy, the progression to 
addressing body weight issues (overweight, underweight 
and weight loss) was addressed at the start of this phase. 
For participants undergoing chemotherapy, the focus on 
diet and weight management was delayed to avoid any 
confusion that might arise with dietary issues related to 
treatment side effects (eg, nausea).
Participants were encouraged to develop personalised 
action and coping plans. Activities (eg, brisk walking) 
were demonstrated and tried by participants. Access to 
an equipment tool kit (pedometers, resistance bands and 
DVDs) was also offered. Emphasis was placed on self-mon-
itoring and goal setting, for example, physical activity 
through pedometers, with weekly feedback in the first 
week of each phase. In phase 2, participants were encour-
aged to commence activity in accordance with ability, 
their postoperative condition and guidance from their 
healthcare team. In phase 3, the participant’s phase 1 
plan was repeated and expanded to include an emphasis 
on core strength, mobility and functional ability, with a 
strict protocol for referral to a physiotherapist if there 
were any safety concerns.
In phase 1, advice for participants not at risk of malnu-
trition (body mass index (BMI)>20 kg/m2) focused on 
avoiding weight gain and increasing nutrient quality of 
their diet in line with the Department of Health Eatwell 
guide.28 Participants were also advised about decreasing 
alcohol intake, as appropriate. No energy prescription 
was set in phase 1. In phase 2 and initially in phase 3, 
nutrition advice focused on symptom management (eg, 
anorexia, vomiting and bowel problems) and worked 
towards achieving a nutrient-dense diet. In the later 
stage of phase 3, all participants (BMI>20 kg/m2) were 
given personalised guidance on a nutrient-dense diet 
and avoidance of excess weight gain. Participants with 
a BMI>25 kg/m2 were advised on avoidance of weight 
gain and modest weight reduction (>5% wt loss) using a 
personalised energy prescription goal. Communications 
emphasised the concept of building resilience through 
the combined approach of increasing muscle mass 
(through physical activity) and decreasing excess body fat 
(through caloric reduction). The importance of regular 
self-weighing was stressed and feedback provided at each 
telephone consultation.
Informed by behaviour change techniques used in 
previous interventions29 and the behaviour change 
wheel,30 a range of evidence-based behavioural tech-
niques were employed to motivate and support lifestyle 
change. These included motivational interviewing, forma-
tion of specific implementation intentions, self-moni-
toring, personalised action and coping plans, feedback 
and re-enforcement.
Measurements
The research nurses prospectively collected details on 
sociodemographic background, clinical information 
(including tumour stage and site), type of surgery, stoma 
status, medications and details of adjuvant treatments.
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Primary outcome measures
Recruitment and retention were assessed from research 
nurse records. Information on reasons why patients were 
ineligible or choose not to participate were recorded with 
patient consent.
Programme implementation (by LCs) was estimated 
from a structured pro forma completed after every patient 
contact which recorded actual values or scaled ratings on:
 ► Intervention start time (days after diagnosis);
 ► Total contact time;
 ► Ease or difficulty of implementing the session;
 ► Perceived fidelity to the intervention content;
 ► Extent of patient engagement, receptivity and 
motivation.
Achieved measurements (by RNs) were recorded at 
baseline and the end of each phase of the study.
Participants’ views on acceptability of the interven-
tion and factors influencing adherence were explored 
in in-depth qualitative interviews conducted by MS and 
JMcK. Interviews were scheduled for around 45–60 min 
and were conducted either face to face or by telephone. 
Interviews were digitally recorded with participants’ 
consent, and transcribed verbatim for analysis. The orig-
inal intention was to interview a random sample of one 
in three participants at the end of phase 2 and another at 
the end of phase 3. However, because of the low number 
of participants everyone was invited to take part in an 
interview towards the end of their journey through the 
intervention programme.
secondary outcome measures
Anthropometric measures were taken as follows:
 ► Body weight measured with the participant wearing 
indoor clothing and no shoes, using a calibrated Seca 
877 digital scale.
 ► Height measured with a Seca Leicester portable 
stadiometer.
 ► BMI was calculated as: weight (kg)/height (m)2.
 ► Waist circumference measured with a Seca 201 meas-
uring tape, with the participant in the standing posi-
tion and the tape positioned midway between the 
lateral lower rib margin and the iliac crest. If these 
landmarks could not be identified, the measurement 
was taken at the level of the umbilicus. Two meas-
urements were taken postexhalation and the mean 
recorded.
Smoking status was self-reported and alcohol intake was 
measured using 7-day alcohol recall31—units of alcohol 
consumed per week and number of alcohol free days per 
week were noted.
Dietary intake was measured using the Dietary Instru-
ment for Nutrition Education questionnaire.32
Physical activity was assessed using the International 
Physical Activity Questionnaire short form33 and the 
6 min walk test.34
Health outcomes of interest were explored—fatigue 
was measured using the multidimensional fatigue inven-
tory-2035 and physical function and quality of life by 
the EORTC GLQ C30 Quality of Life questionnaire for 
patients with bowel cancer and the EORTC GLQ C29 
Quality of Life questionnaire for patients with colorectal 
cancer.36 Bowel function was assessed by the Low Anterior 
Resection Syndrome Score (LARS).37
data analysis
Descriptive statistics allowed characterisation of the 
cohort. Outcome measures were assessed for complete-
ness but no statistical analysis was undertaken given the 
small sample, which was not powered to show definitive 
results.
Data from proformas completed by the LC were anal-
ysed by descriptive statistics (mean±SD) to estimate 
completeness of delivery and areas for improvement, 
and to provide contextual information (including 
National Health Service (NHS) service issues) on patient 
engagement.
Data from the transcripts were coded by MS and JMcK 
using a framework approach,38 with an initial framework 
developed around different aspects of engagement in the 
study and intervention: recruitment and delivery accept-
ability, engagement with lifestyle change, facilitators and 
barriers to lifestyle change and any issues that would need 
to be considered if conducting a full RCT. The frame-
work was revised to incorporate additional themes, which 
emerged from the transcripts (eg, concerning physical 
activity (PA) goals and conflicting advice given by other 
health professionals).
Patient and public involvement
The Chair of Tayside Cancer Patient and Public Involve-
ment Group provided guidance on project development 
and progression. The group also identified a poten-
tial patient representative who subsequently assisted in 
reading and commenting on study design, communi-
cation materials and specific questions. Guidance was 
requested from the patient representative on sensitive 
communications regarding body weight and introducing 
the topic. Patients were not involved in study recruitment.
We have no plans to disseminate the results of this feasi-
bility work to participants.
results
recruitment and retention
Over the 7-month recruitment period (01.04.14 to 
31.10.14), the number of patients diagnosed and 
recorded with colorectal cancer was 84 and 22 (26%) 
were recruited to the study (figure 1). Of the remainder, 
17 were ineligible, unfit or not approached to partic-
ipate and 45 declined to take part, the most common 
reason was the extra burden of the study. It should be 
noted that because of the short window for intervention, 
some participants were recruited before CT scans were 
complete. In one case, lung metastases were diagnosed 
after CT staging. Surgery was still undertaken for this 
 o
n
 15 June 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-021117 on 6 June 2018. Downloaded from 
5Macleod M, et al. BMJ Open 2018;8:e021117. doi:10.1136/bmjopen-2017-021117
Open Access
patient on the clinical basis that it had the potential to 
improve survivorship.
The median age of non-participants was 74 (range 
44–90 years) and 49% were male (table 1). Of the 22 who 
were recruited, the mean age was 67 years and 77% were 
male. Baseline data on BMI and key health behaviours 
(smoking, physical activity, alcohol and diet score) indi-
cate significant potential for health gain.
In total, 15 (68%) completed the study (figure 2). The 
main reason for drop out at all stages was major ill health.
Programme implementation
The median time in phase 1 (prehabilitation) was 15 days. 
The median time in phase 2 was 36.5 days and phase 3 was 
102 days but was frequently extended by clinical problems 
due to health status postsurgery, treatment responses 
and pre-existing comorbidities. Table 2 illustrates the 
significant and varied challenges experienced by indi-
vidual participants during the recovery phase. Many 
patients did not have sufficient time in phase 3 (prior to 
project end) to enable secondary outcomes to be reliably 
assessed.
Total median intervention delivery by lifestyle coun-
sellors was 5 hours 29 mins. LCs reported that patient 
engagement was high, with 93%–100% being at least 
‘fairly engaged’ at all stages. Similarly, the LCs reported 
that participants were receptive and interested in the 
information being delivered.
LCs rated participants as at least ‘fairly motivated’ to 
improve diet and physical activity levels. During the 
immediate recovery stage (phase 2), LCs were most likely 
to report goal setting for diet and PA as ‘neither easy nor 
difficult’ (73% and 64% for diet and PA, respectively). At 
Figure 1 TreatWELL recruitment Consolidated Standards of Reporting Trials flow chart.
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Table 1 Baseline demographic and clinical characteristics by completion*
Recruited n=22 Completed n=15
Dropped out/lost to follow-up 
n=7
Male gender 17 (77%) 11 (73%) 6 (86%)
Age: median (Lower Quartile [LQ], 
Upper Quartile [UQ])
67.0 (60.0, 74.3) 66.0 (60.0, 72.0) 75.0 (64.0, 80.0)
Baseline BMI (kg/m2): median 
(LQ, UQ)
28.3 (25.5, 33.5) 28.6 (26.1, 33.6) 25.8 (24.1, 32.6)
SIMD category
1–3 (most deprived) 5 (23%) 4 (27%) 1 (14%)
4–7 10 (45%) 7 (46%) 3 (43%)
8–10 (most affluent) 7 (32%) 4 (27%) 3 (43%)
Smoking status
Current 2 (9%) 1 (7%) 1 (14%)
Ex-smoker 14 (64%) 10 (67%) 4 (57%)
Never smoked 6 (27%) 4 (26%) 2 (28%)
Treatments
Chemotherapy and radiotherapy 3 (14%) 2 (13%) 1 (14%)
Chemotherapy only 6 (27%) 5 (33%) 1 (14%)
No oncology 10 (45%) 8 (53%) 2 (29%)
Palliative care 3 (14%) 0 (0%) 3 (43%)
Cancer staging
Duke A 3 (14%) 3 (20%) 0 (0%)
Duke B 6 (27%) 3 (20%) 3 (42%)
Duke C 8 (36%) 6 (40%) 2 (29%)
Squamous cell carcinoma 2 (9%) 2 (13%) 0 (0%)
Well-differentiated 
neuroendocrine
1 (5%) 1 (7%) 0 (0%)
Metastases 2 (9%) 0 (0%) 2 (29%)
Behaviours impacting on cancer risk
Smoker: n (%) 2 (9%) 1 (7%) 1 (14%)
Alcohol consumers: n (%) 15 (68%) 10 (67%) 5 (71%)
Alcohol consumption (units per 
week): median (LQ, UQ)
Range
10 (4, 22)
1–70
12.5 (3.75, 53.25)
3–70
11.0 (~)†
~
Alcohol free days: median (LQ, 
UQ)
Range
4 (1, 5)
0–6
3.5 (1.0, 5.0)
0–6
0 (~)†
~
Leisure PA (min): median (LQ, UQ)
Range
480 (227, 709)
40–2070
480 (240, 705)
40–2070
480 (190, 735)
150–1030
Work PA (min): median (LQ, UQ)
Range
1800 (163, 4200)
125–4800
200 (~)‡
125–4800
2700 (~)‡
1800–3600
Total PA (work+leisure): median 
(LQ, UQ)
Range
532 (228, 886)
40–5250
480 (240, 720)
40–5250
649 (190, 2830)
150–4080
Fat rating score: median (LQ, UQ)
Range
32.0 (26.75, 41.25)
16–64
32.0 (27.0, 42.0)
17–64
29.0 (26.0, 37.0)
16–44
Fibre rating score: median (LQ, 
UQ)
Range
30.5 (25.5, 40.0)
10–50
31.0 (28.0, 40.0)
10–50
27.0 (24.0, 40.0)
15–40
*All results are n (%) unless stated otherwise.
†n=1.
‡<4 participants in work. 
BMI, body mass index; SIMD, Scottish Index of Multiple Deprivation. 
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the phase 3a time point, LCs rated the ease of goal setting 
more favourably, with 46% of consultations described as 
‘easy’ to set dietary goals and 82% for PA.
Achieved measurements
Baseline measures were completed on all participants, 
except in four cases, where the 6 min walk test had to 
be excluded due to lack of space in the participant’s 
home. Only 6 out of 33 participants were seen at the end 
of phase 1 due to the difficulty in fitting in visits prior 
to surgery. All participants remaining in the study were 
seen at the end of phase 2, but it was not possible to 
carry out all anthropometric measurements and walking 
tests at this point. Walking tests were not possible at the 
end of phase 3. Questionnaire data were generally well 
completed; however, some participants were reluctant to 
Figure 2 TreatWELL study progression CONSORT flow chart.
 o
n
 15 June 2018 by guest. Protected by copyright.
http://bmjopen.bmj.com/
BM
J O
pen: first published as 10.1136/bmjopen-2017-021117 on 6 June 2018. Downloaded from 
8 Macleod M, et al. BMJ Open 2018;8:e021117. doi:10.1136/bmjopen-2017-021117
Open Access 
answer sexual function questions (LARS questionnaire) 
in all phases.
Factors affecting protocol adherence
The LCs reported that they were able to cover most of the 
intervention components during phase 1 (78% delivery), 
3a (73% delivery) and 3b (90% delivery). However, during 
the postsurgical phase (phase 2), LCs reported difficulties 
with access to patients. Lifestyle counselling was reported 
as most challenging during visits 1 (first contact) and 
2 (immediately postsurgery). Delivery became more 
comfortable towards the end, with LCs reporting 70% of 
the final sessions as ‘fairly easy’ (compared with 39% in 
phase 1 and 46% in phase 2).
The major challenges of intervention delivery reported 
by the LCs were:
 ► The short time between diagnosis and surgery;
 ► Participants identifying time to fit in the baseline and 
intervention visits in addition to diagnostic and treat-
ment preparation schedules;
 ► Seeing patients in phase 2 (short period);
 ► Difficulties identifying the transition from end of 
phase 2 and start of phase 3;
 ► Poor clinical progress (some patients were 
readmitted);
 ► Due to complications, a longer treatment period was 
required that extended phase 3 beyond the project 
life;
 ► Mixed messages from NHS staff and TreatWELL LCs.
Participants views on acceptability
Of 20 participants who completed phase 2II, 14 were invited 
for interview, 3 declined and 11 participated (7 men and 
4 women), with a mean age of 66±6 (range 57–75) years. 
Interviewees were from a range of areas of deprivation.
Most participants recalled that they had been recruited 
around the time of their diagnosis. For some, this timing 
appeared to have facilitated participation, as the study 
offered a potentially beneficial experience on which to 
focus, taking their mind off their diagnosis and concerns 
for the future. Several were reassured by the endorse-
ment of colorectal consultants. Generally, the amount 
of contact, and the balance between visits and telephone 
calls, appeared acceptable, and the provision of home 
visits was particularly appreciated. Some appeared a little 
apprehensive about the prospect of ‘going it alone’ at the 
end of the study but they recognised that its end signalled 
another milestone in their recovery. Participants spoke 
positively of LCs and felt that LCs had been able to move 
them gently into doing things they might have been 
Table 2 Summary of participants’ clinical progress during 
the TreatWELL study 
1 Biopsy showed advanced disease after patient had undergone 
baseline measures and the phase 1 LC intervention visit. Patient 
excluded from further study measures.
2 Surgery as planned but poor postoperative recovery and 
discharged to a continuing care unit. Intravenous chemotherapy 
started after discharge home followed by oral chemotherapy 
and radiotherapy. Waiting for stoma reversal. All phases of study 
completed.
3 Surgery as planned. Slow recovery postsurgery and on parenteral 
nutrition. No adjuvant therapies required. Discharged home with 
carers twice a day, walking with a Zimmer frame. May have further 
surgery and did not progress beyond phase 2 in study. Seen at 
peripheral hospital.
4 Surgery as planned. No adjuvant therapies required. Became 
worried about recurrence after discharge and had to have 
psychological support. Hip pain restarted in phase 3. Lung 
metastases and heart failure diagnosed. Dropped out during phase 
3. Patient died.
5 Surgery as planned. No adjuvant therapies required. All study 
phases completed.
6 Short phase 1. Emergency surgery to defunction bowel (stoma 
formation). Successful chemotherapy and radiotherapy before main 
surgery. Phases 2 and 3 switched round for this participant. All 
study phases completed.
7 Surgery as planned then admission to high dependency unit 
postoperatively. Discharged but readmitted for further surgery 
and stoma formation. Chemotherapy given. All study phases 
completed.
8 Surgery performed. Further surgery performed for removal of 
residual tumour. Stoma reversed. No adjuvant therapies required. 
All study phases completed.
9 Biopsy showed advanced disease after patient had undergone 
baseline measures. Patient not going ahead for surgery and 
excluded from further study measures.
10 Surgery as planned and chemotherapy. Admitted with diabetic 
ketoacidosis but diabetes since resolved. Slow recovery. Phase 1 
delivered day before surgery. Phase 2 and 3 of study completed.
11 Short phase 1. Surgery performed. No adjuvant therapies required. 
Completed phase 2 and 3 of the study.
12 Phase 1 delivered day before surgery. Surgery performed. 
Chemotherapy commenced early due to cancellation in clinic 
and completed. Phase 2 completed. Wife has health issues that 
prevented him completing phase 3.
13 Surgery as planned, No adjuvant therapies required. All phases of 
study completed. Home visits.
14 Surgery as planned and chemotherapy started after surgery. All 
study phases completed. Seen at peripheral hospital.
15 Surgery as planned and no chemotherapy required. All phases of 
study completed (short phase 1). Home visits.
16 Surgery as planned, no adjuvant therapies required. All phases of 
study completed. Home visits.
17 Surgery as planned. Oral chemotherapy after surgery. All phases of 
study completed.
18 For defunctioning stoma and presurgery radiotherapy and 
chemotherapy. Surgery performed. Lost to follow-up as still 
requiring intensive treatment at study end (phase 1 and 2 only).
19 Surgery as planned but readmitted. Slow recovery from surgery 
with significant complications. Phase 1, 2 and 3. Dropped out of 
study during phase 3 as felt back to normal and did not require 
further support.
20 No phase 1 undertaken. Surgery as planned, long postoperative 
recovery. No adjuvant therapies required. Phase 2 and 3 of study 
completed.
Continued
21 Surgery performed. No adjuvant therapies required. All phases of 
study completed. Home visits.
22 Phase 1 delivered day before surgery. Surgery performed. 
Chemotherapy required. Phase 2 and 3 of study completed.
Participant completed study n=15. Dropped out n=7.
Table 2 Continued 
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reluctant to do. Some hinted that they had relied on the 
counsellor for wider emotional support.
The PA advice appeared to have been particularly 
salient, with most participants being able to describe their 
PA goals and targets. Pedometers were felt to have been 
very helpful. Some described having become so fixed on 
their PA goals that they ‘over-did things’, but most felt 
that the advice had encouraged them to be more active 
and to ‘push’ themselves more than they might other-
wise have done. Participants generally felt that they had 
managed to take on board the diet advice, although some 
had struggled with cutting out ‘treats’.
A number of facilitators and barriers to engagement 
were identified. Prior enjoyment of walking and previous 
experience of weight loss programmes were both benefi-
cial, as were supportive family members who encouraged 
adherence to healthy eating and sometimes participated 
in activity along with the participant. Receiving a diagnosis 
of cancer was a major motivator for adherence. Partici-
pants were determined to overcome their diagnosis and 
quickly regain their health, not least for significant others. 
Similarly, participants were motivated to make changes in 
order to put themselves in the best condition for surgery 
and to optimise their recovery. One woman was motivated 
to maintain a healthy weight during her stay in hospital by 
witnessing fellow patients who were overweight struggling 
with their mobility. Monitoring progress especially with 
regard to levels of PA also provided motivation and some 
enjoyment for participants.
A main factor which negatively affected adherence to 
the intervention was participants’ physical health. Some 
participants felt too unwell to increase PA, although this 
was alleviated for some by building strength gradually, 
while others described comorbidities hampering their 
attempts to be physically active.
Some clinical staff were reported to have advised partic-
ipants to gain weight by eating whatever they liked and 
by not discouraging unhealthier foods, in direct contrast 
to TreatWELL. This inconsistency caused confusion, and 
participants reported following the advice of clinical 
staff. Participants also highlighted that NHS staff had 
little awareness of TreatWELL and appeared to provide 
little encouragement. More generally, it was noted that 
nursing staff did not encourage patients to get up and 
move on the ward.
secondary outcomes
There was no change in smoking habits—one of the two 
smokers at baseline was lost to follow-up and the other 
smoker continued to smoke. The number of participants 
who reported consuming alcohol decreased between 
baseline and end of phase 3, although in some individuals 
intake increased. PA data show a positive trend towards 
increased activity overall. For the 15 who completed the 
study, minutes of physical activity nearly doubled from a 
median of 480 (IQ range 240–720) per week to 840 (IQ 
range 330–1260). This was largely due to an increase 
in leisure time activities, but, a decrease in active time 
at work (few participants continued to work during the 
study period). Dietary data indicated no increase in total 
fat score but a desirable increase in fibre score. Quality of 
life data indicated some increase in global health func-
tion but also increases in anxiety.
The majority of participants had excess weight (77%) 
and 40% were obese at baseline (table 1). None was 
underweight. At the end of phase 2II, body weight 
had decreased as expected in the postsurgical period. 
Despite this weight loss, no underweight individuals were 
detected at the end of phase 3 and the proportion with 
excess weight remained. The 6 min walk test indicated no 
decrease in functional ability by the end of phase 3.
It should be noted however that all secondary outcome 
results were obtained principally to test ability to under-
take measures and are not powered to detect differences. 
dIsCussIOn
While it is recognised that presurgical (prehab) lifestyle 
intervention may have significant impact on improving 
health outcomes in the early months following a diagnosis 
of colorectal cancer, there is little evidence of multicom-
ponent intervention RCTs to support investment in this 
area. This study illustrates the complexities of delivering 
and evaluating such interventions and highlights issues 
that need to be addressed prior to progressing further 
work. The main findings show that it is difficult to recruit 
at diagnosis because of the multitude of investigations 
taking place, the staff’s perceptions of frailty and age 
(although all participants were deemed fit for surgery) 
and the relatively short period available for recruitment, 
baseline data collection and intervention delivery before 
surgery. It is notable that a high proportion of partici-
pants were male (77%) and while national data report39 
that more men are diagnosed with colorectal cancer 
compared with women (54% vs 46%), the proportion in 
this study is higher than anticipated. The reason for this 
is not clear but does indicate the need to explore this 
in future work. Phase 2 was predictably short for most 
patients, but longer in those who had previous illness 
or had developed postsurgical complications. It should 
be noted that because patients were recruited at diag-
nosis, the extent of the disease (ie, stage) was unknown 
and complications were unpredictable. Many partici-
pants spent insufficient time in phase 3 (prior to study 
end) for the impact of the intervention to be assessed, 
highlighting the need for a longer study duration for 
final outcome measurements. The clinical pathways of 
participants were unpredictable and impacted on study 
retention. The hardest challenge in delivery was when to 
introduce the next phase of the intervention (phase 2 to 
phase 3) because many participants had complex jour-
neys through treatment. These findings highlight that 
compliance with a strict RCT protocol for this type of 
intervention is likely to be difficult. Outcome measures 
were largely acceptable, although consideration should 
be given to whether the more sensitive questions on 
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quality of life are required. Participant views suggest the 
intervention was largely acceptable, and that the focus 
on physical activity was appropriate. The high number 
of patients with excess body weight at study recruitment 
(and exit) is of concern and a future trial encompassing 
weight loss is likely to need long-term support and 
follow-up.
While our recent intervention study40 has tested the 
feasibility of undertaking lifestyle interventions in people 
at high risk of colorectal (and breast) cancer, this study 
(to the best of our knowledge) is the first to have offered 
a comprehensive lifestyle intervention at diagnosis with 
support before, during and after treatment in patients 
with colorectal cancer. Although the study is small and was 
undertaken in a single NHS health board, the results have 
highlighted a wide range of issues that would need to be 
addressed in a full trial of a multicomponent intervention. 
The lack of randomisation means that it is not possible to 
assess whether uptake to an RCT with control condition 
would be similar.
Moug et al41 have recently reviewed 14 RCTs in this 
patient group and concluded that lifestyle interventions 
are feasible in patients with CRC. However, it is notable 
that there were no RCTs of tobacco and alcohol. In 
general, they reported variable recruitment rates but good 
adherence and retention (as is the case in our own study). 
Ravasco et al13 have demonstrated positive outcomes in 
patients with CRC referred for radiotherapy (irrespec-
tive of other therapies provided) after dietary counsel-
ling. However, other trials of diet and lifestyle have been 
focused on patients after the end of treatment.14 42 43 The 
challenges to conducting a trial in this patient group are 
similar to those described by Hubbard et al44 in feasibility 
work of a pragmatic RCT for a group-based rehabilitation 
programme for CRC survivors, which reported a high 
likelihood of recruitment bias, potential of suboptimal 
completion of outcome data, missing data and poor inter-
vention adherence.
It is important to note that no specific progression 
criteria were identified (or agreed) for trial progression in 
the current study, but each of the parameters identified are 
relevant in decisions around future progression (recruit-
ment, retention, programme implementation, achieved 
measures, fidelity, factors affecting protocol adherence and 
acceptability). The findings show that the recruitment was 
too low (both due to eligibility, people approached and 
willingness to participate), too many participants failed 
to complete because of major health problems, the inter-
vention delivery varied widely from the protocol (in terms 
of timing and approaches) and the number of achieved 
measures (notably at end of phase 1) would be inadequate 
to provide any indication of impact.
In accordance with the study by Thabane et al,45 there are 
four possible progression outcomes as follows: (i) Stop main 
study not feasible;(ii) Continue, but modify protocol feasible 
with modifications;(iii) Continue without modifications, but 
monitor closely feasible with close monitoring and(iv) Continue 
without modifications feasible as is.
Our results suggest that it would be plausible to 
continue but that the protocol should be modified and 
further feasibility testing undertaken prior to a full trial.
The current intervention approach is ambitious, but 
could be refined for testing in an RCT if all visits can be 
linked more closely with clinical appointments, measure-
ment visits are reduced and if the clinical team were 
encouraged to help support lifestyle changes. Funda-
mentally, interventions being tested should be scalable, 
durable and cost-effective.46 While there is much practical 
guidance on diet and lifestyle for cancer survivors47 48 and 
interventions that have been demonstrated to be safe and 
feasible, there remains a need for studies that can demon-
strate the impact of lifestyle intervention on disease 
outcomes. Research in this area requires multilevel 
approaches with full support from health service staff 
(both in recruitment and support for lifestyle action), 
intervention staff for the delivery of tailored, personalised 
approaches and patient interest and advocacy.
COnClusIOns
To make this intervention feasible for testing as a full RCT, 
further research is required on (a) recruitment optimis-
ation, (b) appropriate assessment tools, (c) protocols for 
phase 2 and 3 that can build in flexibility and (d) ways for 
NHS staff to facilitate the programme.
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